Cheil Bio Co (052670.KQ) Stock Price

Cheil Bio Co Price

CLOSED
320,000.00
​
Market closed

Over the last 19 years Cheil Bio Co grew revenue by 0.3% annually, reaching 13.91 B KRW. Earnings per share have grown at 15.9% per year over the last 15 years. For Cheil Bio Co, the net margin of -3.0% is down versus 5.2% a few years ago. At today's price the dividend yield works out to roughly 0.00%. The payout ratio is around 51% of earnings.

Cheil Bio Co stock price

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cheil Bio Co business model & stock analysis

Cheil Bio Co., Ltd. generates revenue through the production and sale of veterinary products for pigs, cattle, chickens, cows, and aquatic animals. The company offers antibiotics, antimicrobials, lactobacillus, enzyme preparations, parasiticides, antiseptics, organic trace minerals, vaccines, and diagnostic kits including ELISA test kits, virus test kits, and DNA kits. These products are primarily sold to the domestic market, targeting livestock farmers and veterinary clinics. The firm also provides feed additives as part of its product portfolio. The company's product range includes specialized solutions for cattle, pigs, chickens, pets, and other animals, with a focus on health management and disease prevention. Veterinary clinics and livestock farms form the core customer segments, purchasing antibiotics, vaccines, and diagnostic tools to maintain animal health. The domestic market remains the primary sales channel, with no mention of international distribution. Cheil Bio's offerings are designed to address common health challenges in livestock, such as infections and parasitic infestations, through both preventive and therapeutic products. The inclusion of diagnostic kits like ELISA and DNA tests supports advanced veterinary care, enhancing the company's value proposition for professional animal health providers.

Frequently asked questions about Cheil Bio Co

Converted at the current exchange rate, the Cheil Bio Co share trades at 217.74 EUR (320,000.00 KRW).

The revenue cannot currently be calculated for Cheil Bio Co.

The profit cannot currently be calculated for Cheil Bio Co.

The P/E ratio cannot be calculated for Cheil Bio Co at the moment.

The P/S cannot be calculated for Cheil Bio Co currently.

The Eulerpool Quality Score for Cheil Bio Co is 1/10.

The ISIN of Cheil Bio Co is KR7052670007. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Cheil Bio Co is 052670.KQ. The ticker symbol is used to trade Cheil Bio Co shares on the stock exchange.

Fair ValueTerminal
262,400.00 KRW
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
309.06 M KRW
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Website cheilbio.com
Country
South Korea
Currency
KRW
Initial public offering
Jan 24, 2002
ISIN
KR7052670007
Cusip
Y1296Y109
Market capitalization
8.65 T KRWMega Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/Se
—
EV/EBIT
—
P/B Ratio
278.54
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
-4.62 %
Dividend
Dividend yield
0.00 %
Payout Ratio
44.84 %
Dividend growth Ø5Y
—
Dividend payments per year
1
Dividend paid since
0 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
22.00 %
Last updated Nov 17, 2026, 10:55 AM

Cheil Bio Co Peer Group

Cheil Bio Co FIGI

052670:KS · BBG000LKKGD9052670:KQ · BBG000LKKGS3

All fundamentals and in-depth analysis of Cheil Bio Co

Our stock analysis for Cheil Bio Co stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Cheil Bio Co. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.